No, Not All Vaccines for Infants Below 12 Months Are Non-Live Attenuated
Rotavirus vaccine, which is a live attenuated vaccine, is routinely administered to infants starting at 6 weeks of age and must be completed by 32 weeks of age (before 8 months), making it a standard live vaccine given well before 12 months of age 1.
Vaccine Types Given Before 12 Months
Live Attenuated Vaccines (Given Before 12 Months)
- Rotavirus (Rota): Live attenuated oral vaccine administered starting at 6-12 weeks of age, with the series completed by 32 weeks of age 1
- Oral Polio Vaccine (OPV): While the U.S. uses inactivated IPV, OPV is a live attenuated vaccine used in many countries and can be given at birth 2
- BCG (Bacillus Calmette-Guérin): Live attenuated vaccine against tuberculosis, widely used at birth in many countries globally 2
Non-Live (Inactivated/Subunit) Vaccines (Given Before 12 Months)
- Hepatitis B (HepB): Inactivated vaccine given at birth 1
- DTaP (Diphtheria, Tetanus, Pertussis): Inactivated/toxoid vaccine starting at 6 weeks 1
- Haemophilus influenzae type b (Hib): Conjugate vaccine (non-live) starting at 6 weeks 1
- Pneumococcal Conjugate (PCV): Non-live conjugate vaccine starting at 6 weeks 1
- Inactivated Poliovirus (IPV): Inactivated vaccine starting at 6 weeks 1
- Influenza (TIV): Trivalent inactivated vaccine starting at 6 months 1
Important Caveats
Live Attenuated Vaccines Typically Delayed Until 12 Months
The following live vaccines have a minimum age of 12 months and are NOT given before this age 1:
- MMR (Measles, Mumps, Rubella): Minimum age 12 months
- Varicella: Minimum age 12 months
- Hepatitis A: Minimum age 12 months
- LAIV (Live Attenuated Influenza Vaccine): Minimum age 5 years (not used in infants at all) 1
Why This Distinction Matters Clinically
The presence of maternal antibodies and immune system immaturity in infants under 12 months generally reduces the effectiveness of live attenuated vaccines targeting viral infections like measles, mumps, and rubella 3, 4. However, rotavirus vaccine is specifically designed to work in young infants despite these limitations, which is why it's both safe and effective when given starting at 6 weeks of age.
Critical safety note: The rotavirus series must be initiated between 6-12 weeks and completed by 32 weeks of age due to insufficient safety data outside these age ranges 1.